| Title : The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation - Pang_2023_Physiol.Behav_263_114134 |
| Author(s) : Pang B , Zhang LL , Li B , Sun FX , Wang ZD |
| Ref : Physiol Behav , 263 :114134 , 2023 |
| Abstract : |
| PubMedSearch : Pang_2023_Physiol.Behav_263_114134 |
| PubMedID: 36809844 |
| Title : The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation - Pang_2023_Physiol.Behav_263_114134 |
| Author(s) : Pang B , Zhang LL , Li B , Sun FX , Wang ZD |
| Ref : Physiol Behav , 263 :114134 , 2023 |
| Abstract : |
| PubMedSearch : Pang_2023_Physiol.Behav_263_114134 |
| PubMedID: 36809844 |
| Title : The sodium glucose co-transporter 2 inhibitor ertugliflozin for Alzheimer's disease: Inhibition of brain insulin signaling disruption-induced tau hyperphosphorylation - Pang_2023_Physiol.Behav_263_114134 |
| Author(s) : Pang B , Zhang LL , Li B , Sun FX , Wang ZD |
| Ref : Physiol Behav , 263 :114134 , 2023 |
| Abstract : |
| PubMedSearch : Pang_2023_Physiol.Behav_263_114134 |
| PubMedID: 36809844 |